Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government whether deceased people impacted by infected blood are entitled to the Level 2B award, as set out in their response to the consultation on changes to the infected blood compensation scheme, published on 14 April.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
Yes, deceased infected people will be eligible. As set out in the Government’s response to the consultation, the Government will introduce a Level 2B banding to recognise the harms caused by treatment with interferon. Anyone who can evidence treatment with interferon (with or without other drugs, such as ribavirin) will automatically qualify for Level 2B, without having to prove the duration of their treatment, side effects, financial loss or care needs. This includes the estates of deceased infected people.
Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government whether deceased people impacted by infected blood are entitled to the Unethical Research award, as set out in their response to the consultation on changes to the infected blood compensation scheme, published on 14 April.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
Yes, deceased infected people will be eligible. As set out in the Government’s response to the consultation, every eligible infected person treated for a bleeding disorder within a specific time period will receive an unethical research award. Additionally, people who were treated for a bleeding disorder in childhood will receive a higher Unethical Research award than those who were treated in adulthood. The amounts available through these awards do not change based on whether the infected person is living or has died.
Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government how many claims for compensation via the Infected Blood Compensation Authority have been paid so far, including how many claims have been paid to (1) people who have been infected but not previously registered with a support scheme, (2) estates of people who were infected but have since died, and (3) affected people.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
The delivery of compensation is a matter for the independent Infected Blood Compensation Authority (IBCA).
IBCA publishes updated statistics every fortnight on its website. As of 19 May 2026, a total of 3,272 people have had their compensation paid. This includes:
3,198 living infected people registered with an existing support scheme;
21 living infected people who have never been compensated;
23 people acting on behalf of a deceased infected person;
30 affected people.
The latest update can be found here: https://ibca.org.uk/statistics/registration-and-compensation-progress-update-21-may-2026/.
Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government what consideration they have given to introducing a tax on companies which benefited from (1) the research conducted on British infected blood victims, and (2) the drugs used to treat infected blood patients; and what assessment they have made of the benefits and risks of taxing those companies.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
The Infected Blood Inquiry recommended that a compensation scheme be set up as soon as possible, and by centrally funding the scheme, the Government has been able quickly allocate the money necessary.
The Government firmly believes that access to redress is fundamental in upholding justice and fairness in our society. People must have avenues to seek recourse when they have been wronged or harmed. We hope the Infected Blood Compensation Scheme provides some closure to those who have been wronged under some of those most devastating circumstances.
Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government what plans they have to provide compensation for career damage and financial loss for victims in the infected blood scheme who were unable to complete or build on their training or qualifications.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
The Financial Loss award is designed to compensate for past and future financial losses suffered as a result of infection. For people infected with HIV or chronic Hepatitis infections, this is calculated based on the average anticipated loss of earnings they would have suffered as a result of their infection and subsequent treatment.
In some exceptional cases, infected people will have suffered greater financial losses as a result of their infection than they will be compensated for as part of their core route award. This might be, for example, where they had particularly high earnings prior to their infection. Infected people in this situation can apply for an Exceptional Loss award through the Scheme’s supplementary route, and if eligible, receive additional financial loss compensation to reflect their circumstances.
The Inquiry’s Additional Report included a recommendation to consult on whether these evidence requirements mean that some people who ought to be eligible for the award are prevented from accessing it, and whether there are ways to address this.
The consultation asked respondents to consider forms of evidence for loss of earnings, fairness for applicants to the Scheme, and the types of evidence the Infected Blood Compensation Authority could take into account when someone no longer has documentary evidence to prove they earned beyond what is provided for under the core route. The consultation closed on 22 January. The Minister for the Cabinet Office hopes to update Parliament soon on the changes the Government intends to make to the compensation scheme, as a result of the public consultation.
Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government what consideration they gave to the treatment of estates in the consultation on the proposed changes to the infected blood compensation scheme which ended on 22 January.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
On 30 October, the Government launched a public consultation on proposed changes to the infected blood compensation scheme. The Government particularly welcomes responses from those in the infected blood community, including estate representatives, and family members who sadly have lost a loved one due to the use of infected blood, or infected blood products.
Some of the proposals set out in the consultation will have an impact on claims made by estate representatives, on behalf of a deceased infected person. The consultation focused on the areas recommended by the Infected Blood Inquiry in its Additional Report. It also asked whether a respondent would like to raise other issues around the compensation scheme that may not have been addressed in the Additional Report.
The Government is carefully considering responses to the consultation, which closed on 22 January. The Minister for the Cabinet Office hopes to update Parliament soon on the changes the Government intends to make to the compensation scheme, as a result of the public consultation.
Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government what steps they took to consult the community of infected blood victims as part of the consultation on proposed changes to the infected blood compensation scheme which ended on 22 January.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
On 30 October, the Government launched a public consultation on proposed changes to the infected blood compensation scheme. In that consultation document, the Government explained that it welcomed responses from all those with an interest in the changes, and especially those in the infected blood community. This consultation has been an important step toward ensuring those impacted are involved in the decision-making process, and I am grateful to all those who took the time to respond. The core purpose of the consultation is to gather views on how the Government intends to implement the Inquiry’s recommendations. Every response to this consultation is being considered carefully and with the seriousness the issue deserves.
The consultation closed on 22 January. The Minister for the Cabinet Office hopes Parliament soon on the changes the Government intends to make to the compensation scheme, as a result of the public consultation.
Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government what plans they have for specific regulatory provisions to compensate the estates of those who died as a result of being given infected blood products for mental health injuries such as (1) suicide, (2) attempted suicide, and (3) other severe impairments; and what plans they have to acknowledge and compensate the estates of the deceased for additional claims for mental injury beyond the core compensation claims route.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
The Infected Blood Compensation Scheme currently provides compensation for psychological harm through both the core and supplementary route, depending on the type and severity of harm. Under the supplementary route, the Severe Health Condition award offers additional compensation where someone has been diagnosed with a severe psychiatric disorder that has caused suffering beyond what is recognised and compensated for as part of their core award. The estates of deceased infected people are eligible for the core route, and to apply for the supplementary route.
The Government has recently consulted on the expansion of eligibility for a Severe Health Condition award for infected people who meet the criteria for the Special Category Mechanism (SCM) or equivalent payments. It also proposes that severe mental health issues not covered in the core route or by the existing Severe Health Condition award are compensated for by this new route. The Government has not proposed that estates of deceased infected people, unless they were receiving SCM or equivalent payments at the time of death, are eligible for this award. The Minister for the Cabinet Office hopes to update Parliament soon on the changes the Government intends to make to the compensation scheme, as a result of the public consultation.
Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government what assessment they have made of the consequences of people who died as a result of infected blood being paid less under the Infected Blood Compensation Scheme than those who are still alive.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
An infected person’s compensation (while living or as an estate) is calculated in line with five Categories of Award to recognise and compensate for the impacts of the infected blood scandal in different areas of a person’s life - these are an Injury Award, Social Impact Award, Autonomy Award, Care Award and Financial Loss Award. For the first three (Injury, Social Impact and Autonomy) the award amounts are the same whether someone applies to the scheme for compensation whilst they are still alive, or whether a personal representative of their estate makes an application.
Where an infected person has passed away before they have applied to the Infected Blood Compensation Authority (IBCA), the estate will be able to make a claim on the infected person’s behalf. In that claim, financial loss from the point of infection to the point of the infected person’s death will be paid to the estate. This recognises the loss of earnings that a person likely suffered because of their illness. Financial loss is not paid to the estate for any years after the year of that person’s death. This is because the person cannot have had reduced earnings after they passed away. Instead, those who were financially dependent on them at the point of their death will have suffered from the reduced earnings caused by their death.
The Cabinet Office has carried out analysis under the Public Sector Equality Duty for all regulations made to establish the Infected Blood Compensation Scheme. The most recent analysis was published in October.
Asked by: Baroness Featherstone (Liberal Democrat - Life peer)
Question to the Cabinet Office:
To ask His Majesty's Government what assessment they have made of the impact on carers, particularly women, of the Infected Blood Compensation Scheme paying awards for past care directly to the estate of the deceased, in particular in relation to Articles 4, 5, 6, 8 and 14 of the Human Rights Act 1998.
Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)
The Care award is provided to people making a claim as an infected person or as their estate representative. A living infected person receiving compensation can take a decision on whether all or some of this award should be passed to an affected person. Care awards paid to infected people can therefore be paid directly to affected people on the request of an infected person.
An executor of a deceased infected person's estate will be responsible for administering the estate as per the wishes of the infected person.
The Cabinet Office has carried out analysis under the Public Sector Equality Duty for all regulations made to establish the Infected Blood Compensation Scheme. The most recent analysis was published in October and can be viewed here: https://www.legislation.gov.uk/ukdsi/2025/9780348276077/pdfs/ukdsipes_9780348276077_en_001.pdf.